UniProt ID | FAK1_HUMAN | |
---|---|---|
UniProt AC | Q05397 | |
Protein Name | Focal adhesion kinase 1 | |
Gene Name | PTK2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1052 | |
Subcellular Localization |
Cell junction, focal adhesion. Cell membrane Peripheral membrane protein Cytoplasmic side. Cytoplasm, cell cortex. Cytoplasm, cytoskeleton. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Nucleus. Constituent of focal adhesions. |
|
Protein Description | Non-receptor protein-tyrosine kinase that plays an essential role in regulating cell migration, adhesion, spreading, reorganization of the actin cytoskeleton, formation and disassembly of focal adhesions and cell protrusions, cell cycle progression, cell proliferation and apoptosis. Required for early embryonic development and placenta development. Required for embryonic angiogenesis, normal cardiomyocyte migration and proliferation, and normal heart development. Regulates axon growth and neuronal cell migration, axon branching and synapse formation; required for normal development of the nervous system. Plays a role in osteogenesis and differentiation of osteoblasts. Functions in integrin signal transduction, but also in signaling downstream of numerous growth factor receptors, G-protein coupled receptors (GPCR), EPHA2, netrin receptors and LDL receptors. Forms multisubunit signaling complexes with SRC and SRC family members upon activation; this leads to the phosphorylation of additional tyrosine residues, creating binding sites for scaffold proteins, effectors and substrates. Regulates numerous signaling pathways. Promotes activation of phosphatidylinositol 3-kinase and the AKT1 signaling cascade. Promotes activation of MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling cascade. Promotes localized and transient activation of guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs), and thereby modulates the activity of Rho family GTPases. Signaling via CAS family members mediates activation of RAC1. Recruits the ubiquitin ligase MDM2 to P53/TP53 in the nucleus, and thereby regulates P53/TP53 activity, P53/TP53 ubiquitination and proteasomal degradation. Phosphorylates SRC; this increases SRC kinase activity. Phosphorylates ACTN1, ARHGEF7, GRB7, RET and WASL. Promotes phosphorylation of PXN and STAT1; most likely PXN and STAT1 are phosphorylated by a SRC family kinase that is recruited to autophosphorylated PTK2/FAK1, rather than by PTK2/FAK1 itself. Promotes phosphorylation of BCAR1; GIT2 and SHC1; this requires both SRC and PTK2/FAK1. Promotes phosphorylation of BMX and PIK3R1. Isoform 6 (FRNK) does not contain a kinase domain and inhibits PTK2/FAK1 phosphorylation and signaling. Its enhanced expression can attenuate the nuclear accumulation of LPXN and limit its ability to enhance serum response factor (SRF)-dependent gene transcription.. | |
Protein Sequence | MAAAYLDPNLNHTPNSSTKTHLGTGMERSPGAMERVLKVFHYFESNSEPTTWASIIRHGDATDVRGIIQKIVDSHKVKHVACYGFRLSHLRSEEVHWLHVDMGVSSVREKYELAHPPEEWKYELRIRYLPKGFLNQFTEDKPTLNFFYQQVKSDYMLEIADQVDQEIALKLGCLEIRRSYWEMRGNALEKKSNYEVLEKDVGLKRFFPKSLLDSVKAKTLRKLIQQTFRQFANLNREESILKFFEILSPVYRFDKECFKCALGSSWIISVELAIGPEEGISYLTDKGCNPTHLADFTQVQTIQYSNSEDKDRKGMLQLKIAGAPEPLTVTAPSLTIAENMADLIDGYCRLVNGTSQSFIIRPQKEGERALPSIPKLANSEKQGMRTHAVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQQEERMRMESRRQATVSWDSGGSDEAPPKPSRPGYPSPRSSEGFYPSPQHMVQTNHYQVSGYPGSHGITAMAGSIYPGQASLLDQTDSWNHRPQEIAMWQPNVEDSTVLDLRGIGQVLPTHLMEERLIRQQQEMEEDQRWLEKEERFLKPDVRLSRGSIDREDGSLQGPIGNQHIYQPVGKPDPAAPPKKPPRPGAPGHLGSLASLSSPADSYNEGVKLQPQEISPPPTANLDRSNDKVYENVTGLVKAVIEMSSKIQPAPPEEYVPMVKEVGLALRTLLATVDETIPLLPASTHREIEMAQKLLNSDLGELINKMKLAQQYVMTSLQQEYKKQMLTAAHALAVDAKNLLDVIDQARLKMLGQTRPH | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAAAYLDPN ------CCCCCCCCC | 16.47 | 19369195 | |
5 | Phosphorylation | ---MAAAYLDPNLNH ---CCCCCCCCCCCC | 13.60 | 25159151 | |
13 | Phosphorylation | LDPNLNHTPNSSTKT CCCCCCCCCCCCCCC | 24.08 | 25159151 | |
16 | Phosphorylation | NLNHTPNSSTKTHLG CCCCCCCCCCCCCCC | 40.36 | 25159151 | |
17 | Phosphorylation | LNHTPNSSTKTHLGT CCCCCCCCCCCCCCC | 40.33 | 22199227 | |
18 | Phosphorylation | NHTPNSSTKTHLGTG CCCCCCCCCCCCCCC | 39.52 | 22199227 | |
20 | Phosphorylation | TPNSSTKTHLGTGME CCCCCCCCCCCCCCC | 23.56 | 23403867 | |
24 | Phosphorylation | STKTHLGTGMERSPG CCCCCCCCCCCCCCC | 39.45 | 27696853 | |
29 | Phosphorylation | LGTGMERSPGAMERV CCCCCCCCCCHHHHH | 17.87 | 25159151 | |
54 | Phosphorylation | SEPTTWASIIRHGDA CCCCCHHHHHHCCCC | 15.31 | - | |
65 | Methylation | HGDATDVRGIIQKIV CCCCCCHHHHHHHHH | 33.14 | - | |
70 | Ubiquitination | DVRGIIQKIVDSHKV CHHHHHHHHHHCCCC | 34.00 | - | |
131 | Sumoylation | LRIRYLPKGFLNQFT EEEEECCCCHHHHHC | 60.75 | - | |
131 | Sumoylation | LRIRYLPKGFLNQFT EEEEECCCCHHHHHC | 60.75 | 14500712 | |
148 | Phosphorylation | KPTLNFFYQQVKSDY CCCHHHHHHHHCCCH | 8.22 | 17117420 | |
152 | Sumoylation | NFFYQQVKSDYMLEI HHHHHHHCCCHHHHH | 33.02 | - | |
155 | Phosphorylation | YQQVKSDYMLEIADQ HHHHCCCHHHHHHHH | 15.64 | 17117420 | |
194 | Phosphorylation | ALEKKSNYEVLEKDV HHHHHCCHHHHHHHH | 17.95 | 20802513 | |
199 | Ubiquitination | SNYEVLEKDVGLKRF CCHHHHHHHHCCHHH | 54.26 | - | |
216 | Ubiquitination | KSLLDSVKAKTLRKL HHHHHHHHHHHHHHH | 48.38 | - | |
222 | Malonylation | VKAKTLRKLIQQTFR HHHHHHHHHHHHHHH | 53.72 | 26320211 | |
239 | Phosphorylation | ANLNREESILKFFEI HCCCHHHHHHHHHHH | 28.59 | 24719451 | |
248 | Phosphorylation | LKFFEILSPVYRFDK HHHHHHHCCHHCCCH | 20.27 | 21406692 | |
251 | Phosphorylation | FEILSPVYRFDKECF HHHHCCHHCCCHHHH | 14.67 | 21406692 | |
347 | Phosphorylation | MADLIDGYCRLVNGT HHHHHHHCHHHHCCC | 3.17 | 11853674 | |
364 | Ubiquitination | SFIIRPQKEGERALP CEEECCCCCCCCCCC | 71.07 | - | |
372 | Phosphorylation | EGERALPSIPKLANS CCCCCCCCCHHHCCC | 52.99 | 23532336 | |
386 | Phosphorylation | SEKQGMRTHAVSVSE CCCCCCCCEEEEECC | 12.80 | 28176443 | |
390 | Phosphorylation | GMRTHAVSVSETDDY CCCCEEEEECCCCCC | 22.25 | 22322096 | |
392 | Phosphorylation | RTHAVSVSETDDYAE CCEEEEECCCCCCHH | 27.54 | 28176443 | |
394 | Phosphorylation | HAVSVSETDDYAEII EEEEECCCCCCHHCC | 27.02 | 28176443 | |
397 | Dephosphorylation | SVSETDDYAEIIDEE EECCCCCCHHCCCCC | 14.67 | 11314030 | |
397 | Phosphorylation | SVSETDDYAEIIDEE EECCCCCCHHCCCCC | 14.67 | 12754219 | |
406 | Phosphorylation | EIIDEEDTYTMPSTR HCCCCCCCCCCCCCC | 24.95 | 28176443 | |
407 | Phosphorylation | IIDEEDTYTMPSTRD CCCCCCCCCCCCCCC | 17.23 | 17449913 | |
408 | Phosphorylation | IDEEDTYTMPSTRDY CCCCCCCCCCCCCCH | 25.38 | 18691976 | |
411 | Phosphorylation | EDTYTMPSTRDYEIQ CCCCCCCCCCCHHHH | 25.83 | 26356563 | |
412 | Phosphorylation | DTYTMPSTRDYEIQR CCCCCCCCCCHHHHH | 22.99 | 26356563 | |
441 | Phosphorylation | GDVHQGIYMSPENPA CCCCCCEEECCCCHH | 9.81 | 27259358 | |
443 | Phosphorylation | VHQGIYMSPENPALA CCCCEEECCCCHHHH | 16.46 | 26356563 | |
460 | Phosphorylation | IKTCKNCTSDSVREK HHHCCCCCCHHHHHH | 44.99 | - | |
461 | Phosphorylation | KTCKNCTSDSVREKF HHCCCCCCHHHHHHH | 30.04 | - | |
463 | Phosphorylation | CKNCTSDSVREKFLQ CCCCCCHHHHHHHHH | 23.88 | - | |
467 | Acetylation | TSDSVREKFLQEALT CCHHHHHHHHHHHHH | 40.59 | 19828921 | |
474 | Phosphorylation | KFLQEALTMRQFDHP HHHHHHHHHHHCCCC | 19.84 | - | |
503 | Phosphorylation | WIIMELCTLGELRSF HHHHHHCCHHHHHHH | 50.88 | 17117420 | |
517 | Phosphorylation | FLQVRKYSLDLASLI HHHHHHHHHHHHHHH | 20.60 | 20860994 | |
522 | Phosphorylation | KYSLDLASLILYAYQ HHHHHHHHHHHHHHH | 24.20 | 20860994 | |
526 | Phosphorylation | DLASLILYAYQLSTA HHHHHHHHHHHHHHH | 9.03 | 20860994 | |
568 | Phosphorylation | KLGDFGLSRYMEDST EECCCCHHHHHCCCC | 23.03 | 29255136 | |
570 | Phosphorylation | GDFGLSRYMEDSTYY CCCCHHHHHCCCCEE | 11.07 | 21945579 | |
574 | Phosphorylation | LSRYMEDSTYYKASK HHHHHCCCCEECCCC | 12.66 | 21945579 | |
575 | Phosphorylation | SRYMEDSTYYKASKG HHHHCCCCEECCCCC | 43.10 | 21945579 | |
576 | Phosphorylation | RYMEDSTYYKASKGK HHHCCCCEECCCCCC | 13.61 | 19664994 | |
577 | Phosphorylation | YMEDSTYYKASKGKL HHCCCCEECCCCCCC | 10.52 | 17449913 | |
580 | Phosphorylation | DSTYYKASKGKLPIK CCCEECCCCCCCCCE | 37.48 | 27273156 | |
677 | Phosphorylation | TELKAQLSTILEEEK HHHHHHHHHHHHHHH | 11.00 | 30624053 | |
678 | Phosphorylation | ELKAQLSTILEEEKA HHHHHHHHHHHHHHH | 37.87 | 30624053 | |
684 | Ubiquitination | STILEEEKAQQEERM HHHHHHHHHHHHHHH | 55.57 | - | |
688 (in isoform 2) | Phosphorylation | - | 35.17 | 28796482 | |
695 | Phosphorylation | EERMRMESRRQATVS HHHHHHHHHHHCEEC | 24.34 | - | |
700 | Phosphorylation | MESRRQATVSWDSGG HHHHHHCEECCCCCC | 13.51 | 23663014 | |
702 | Phosphorylation | SRRQATVSWDSGGSD HHHHCEECCCCCCCC | 22.32 | 23927012 | |
705 | Phosphorylation | QATVSWDSGGSDEAP HCEECCCCCCCCCCC | 38.50 | 23927012 | |
708 | Phosphorylation | VSWDSGGSDEAPPKP ECCCCCCCCCCCCCC | 35.48 | 23927012 | |
716 | Phosphorylation | DEAPPKPSRPGYPSP CCCCCCCCCCCCCCC | 58.18 | 30266825 | |
720 | Phosphorylation | PKPSRPGYPSPRSSE CCCCCCCCCCCCCCC | 11.83 | 23927012 | |
722 | Phosphorylation | PSRPGYPSPRSSEGF CCCCCCCCCCCCCCC | 25.18 | 19664994 | |
725 (in isoform 7) | Phosphorylation | - | 35.80 | 22210691 | |
726 | Phosphorylation | GYPSPRSSEGFYPSP CCCCCCCCCCCCCCC | 42.91 | - | |
726 (in isoform 7) | Phosphorylation | - | 42.91 | 22210691 | |
732 | Phosphorylation | SSEGFYPSPQHMVQT CCCCCCCCCCCEEEE | 26.30 | 17096371 | |
742 | Phosphorylation | HMVQTNHYQVSGYPG CEEEECCEECCCCCC | 16.81 | - | |
759 | Phosphorylation | GITAMAGSIYPGQAS CEEEEECCCCCCCHH | 14.92 | - | |
759 (in isoform 7) | Phosphorylation | - | 14.92 | 22210691 | |
761 | Phosphorylation | TAMAGSIYPGQASLL EEEECCCCCCCHHHH | 11.74 | - | |
805 | Phosphorylation | GIGQVLPTHLMEERL CCCHHHCHHHHHHHH | 24.39 | 17855441 | |
840 | Phosphorylation | LKPDVRLSRGSIDRE CCCCCEECCCCCCCC | 24.83 | 28355574 | |
843 | Phosphorylation | DVRLSRGSIDREDGS CCEECCCCCCCCCCC | 21.87 | 21945579 | |
850 | Phosphorylation | SIDREDGSLQGPIGN CCCCCCCCEECCCCC | 29.82 | 21945579 | |
861 | Phosphorylation | PIGNQHIYQPVGKPD CCCCEEEECCCCCCC | 12.49 | 17449913 | |
861 (in isoform 5) | Phosphorylation | - | 12.49 | - | |
887 | Phosphorylation | GAPGHLGSLASLSSP CCCCCHHHHHHCCCC | 27.42 | 21082442 | |
890 | Phosphorylation | GHLGSLASLSSPADS CCHHHHHHCCCCCCC | 33.79 | 26356563 | |
892 | Phosphorylation | LGSLASLSSPADSYN HHHHHHCCCCCCCCC | 31.61 | 26356563 | |
893 | Phosphorylation | GSLASLSSPADSYNE HHHHHCCCCCCCCCC | 29.42 | 29496963 | |
897 | Phosphorylation | SLSSPADSYNEGVKL HCCCCCCCCCCCCCC | 31.78 | 23186163 | |
898 | Phosphorylation | LSSPADSYNEGVKLQ CCCCCCCCCCCCCCC | 20.13 | 25884760 | |
910 | Phosphorylation | KLQPQEISPPPTANL CCCCCCCCCCCCCCC | 30.51 | 17096371 | |
914 | Phosphorylation | QEISPPPTANLDRSN CCCCCCCCCCCCCCC | 33.67 | 23927012 | |
920 | Phosphorylation | PTANLDRSNDKVYEN CCCCCCCCCCHHHHC | 49.39 | 28152594 | |
923 | Ubiquitination | NLDRSNDKVYENVTG CCCCCCCHHHHCHHH | 51.47 | - | |
923 (in isoform 5) | Phosphorylation | - | 51.47 | 30087585 | |
925 | Phosphorylation | DRSNDKVYENVTGLV CCCCCHHHHCHHHHH | 13.92 | 12754219 | |
929 | Phosphorylation | DKVYENVTGLVKAVI CHHHHCHHHHHHHHH | 36.06 | 28152594 | |
963 | Phosphorylation | EVGLALRTLLATVDE HHHHHHHHHHHHHCC | 27.29 | - | |
967 | Phosphorylation | ALRTLLATVDETIPL HHHHHHHHHCCCCCC | 28.58 | - | |
971 | Phosphorylation | LLATVDETIPLLPAS HHHHHCCCCCCCCCC | 24.35 | - | |
1000 | Ubiquitination | DLGELINKMKLAQQY CHHHHHHHHHHHHHH | 30.34 | - | |
1007 | Phosphorylation | KMKLAQQYVMTSLQQ HHHHHHHHHHHHHHH | 4.70 | 17117420 | |
1016 | Phosphorylation | MTSLQQEYKKQMLTA HHHHHHHHHHHHHHH | 21.10 | 18083107 | |
1017 | Acetylation | TSLQQEYKKQMLTAA HHHHHHHHHHHHHHH | 35.46 | 24179899 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
5 | Y | Phosphorylation | Kinase | EGFR | P00533 | PSP |
5 | Y | Phosphorylation | Kinase | MET | P08581 | PSP |
5 | Y | Phosphorylation | Kinase | PDGFRB | P09619 | PSP |
194 | Y | Phosphorylation | Kinase | MET | P08581 | PSP |
194 | Y | Phosphorylation | Kinase | EGFR | P00533 | PSP |
194 | Y | Phosphorylation | Kinase | PDGFRB | P09619 | PSP |
194 | Y | Phosphorylation | Kinase | BMX | P51813 | GPS |
194 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
397 | Y | Phosphorylation | Kinase | MET | P08581 | PSP |
397 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
397 | Y | Phosphorylation | Kinase | PTK2 | Q05397 | GPS |
397 | Y | Phosphorylation | Kinase | FGR | P09769 | PSP |
407 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
407 | Y | Phosphorylation | Kinase | MET | P08581 | PSP |
407 | Y | Phosphorylation | Kinase | PTK2 | Q05397 | GPS |
407 | Y | Phosphorylation | Kinase | PTK2B | Q14289 | GPS |
441 | Y | Phosphorylation | Kinase | BMX | P51813 | GPS |
441 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
576 | Y | Phosphorylation | Kinase | MET | P08581 | PSP |
576 | Y | Phosphorylation | Kinase | FGR | P09769 | PSP |
576 | Y | Phosphorylation | Kinase | RET | P07949 | Uniprot |
576 | Y | Phosphorylation | Kinase | PTK2 | Q05397 | GPS |
576 | Y | Phosphorylation | Kinase | SRC | P12931 | Uniprot |
576 | Y | Phosphorylation | Kinase | BMX | P51813 | GPS |
577 | Y | Phosphorylation | Kinase | PTK2 | Q05397 | GPS |
577 | Y | Phosphorylation | Kinase | RET | P07949 | Uniprot |
577 | Y | Phosphorylation | Kinase | MET | P08581 | PSP |
577 | Y | Phosphorylation | Kinase | SRC | P12931 | Uniprot |
577 | Y | Phosphorylation | Kinase | BMX | P51813 | GPS |
695 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
700 | T | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
732 | S | Phosphorylation | Kinase | ROCK1 | Q13464 | PSP |
732 | S | Phosphorylation | Kinase | CDK5 | Q00535 | Uniprot |
742 | Y | Phosphorylation | Kinase | BMX | P51813 | GPS |
742 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
861 | Y | Phosphorylation | Kinase | MET | P08581 | PSP |
861 | Y | Phosphorylation | Kinase | SRC64 | - | PhosphoELM |
861 | Y | Phosphorylation | Kinase | YES1 | P07947 | GPS |
861 | Y | Phosphorylation | Kinase | RET | P07949 | PSP |
861 | Y | Phosphorylation | Kinase | BMX | P51813 | GPS |
861 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
898 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
898 | Y | Phosphorylation | Kinase | BMX | P51813 | GPS |
910 | S | Phosphorylation | Kinase | CDK5 | Q00535 | PSP |
925 | Y | Phosphorylation | Kinase | MET | P08581 | PSP |
925 | Y | Phosphorylation | Kinase | YES1 | P07947 | GPS |
925 | Y | Phosphorylation | Kinase | BMX | P51813 | GPS |
925 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
925 | Y | Phosphorylation | Kinase | RET | P07949 | PSP |
925 | Y | Phosphorylation | Kinase | FGR | P09769 | PSP |
1007 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
1007 | Y | Phosphorylation | Kinase | BMX | P51813 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
722 | S | Phosphorylation |
| 19339212 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FAK1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-5; THR-13; SER-16;SER-29; THR-386; SER-390; SER-392; THR-394; TYR-397; THR-406; TYR-407;TYR-570; THR-575; TYR-576; TYR-577; SER-580; SER-677; THR-700;SER-702; SER-705; SER-708; SER-716; TYR-720; SER-722; SER-840;SER-843; TYR-861 AND SER-910, PHOSPHORYLATION [LARGE SCALE ANALYSIS]AT TYR-688 (ISOFORM 2), AND MASS SPECTROMETRY. | |
"Specific tyrosine phosphorylation of focal adhesion kinase mediatedby Fer tyrosine kinase in suspended hepatocytes."; Oh M.A., Choi S., Lee M.J., Choi M.C., Lee S.A., Ko W., Cance W.G.,Oh E.S., Buday L., Kim S.H., Lee J.W.; Biochim. Biophys. Acta 1793:781-791(2009). Cited for: PHOSPHORYLATION AT TYR-397; TYR-576; TYR-577; SER-722; TYR-861 ANDTYR-925, AND IDENTIFICATION IN A COMPLEX WITH CTTN AND FER. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-910, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-13; SER-29; SER-568;TYR-570; SER-722; SER-840; SER-887 AND SER-910, AND MASS SPECTROMETRY. | |
"Proteomics analysis of protein kinases by target class-selectiveprefractionation and tandem mass spectrometry."; Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,Keri G., Wehland J., Daub H.; Mol. Cell. Proteomics 6:537-547(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-397; TYR-576; SER-722;SER-840; SER-843 AND SER-910, AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-397 AND SER-840, ANDMASS SPECTROMETRY. | |
"Focal adhesion kinase (FAK) binds RET kinase via its FERM domain,priming a direct and reciprocal RET-FAK transactivation mechanism."; Plaza-Menacho I., Morandi A., Mologni L., Boender P.,Gambacorti-Passerini C., Magee A.I., Hofstra R.M.W., Knowles P.,McDonald N.Q., Isacke C.M.; J. Biol. Chem. 286:17292-17302(2011). Cited for: INTERACTION WITH RET, FUNCTION IN RET PHOSPHORYLATION, ANDPHOSPHORYLATION AT TYR-576 AND TYR-577. | |
"ZF21 protein regulates cell adhesion and motility."; Nagano M., Hoshino D., Sakamoto T., Kawasaki N., Koshikawa N.,Seiki M.; J. Biol. Chem. 285:21013-21022(2010). Cited for: INTERACTION WITH ZFYVE21, AND DEPHOSPHORYLATION AT TYR-397. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-576; TYR-577 ANDTYR-861, AND MASS SPECTROMETRY. | |
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks."; Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.; Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-576, AND MASSSPECTROMETRY. | |
"Inhibition of both focal adhesion kinase and insulin-like growthfactor-I receptor kinase suppresses glioma proliferation in vitro andin vivo."; Liu T.J., LaFortune T., Honda T., Ohmori O., Hatakeyama S., Meyer T.,Jackson D., de Groot J., Yung W.K.; Mol. Cancer Ther. 6:1357-1367(2007). Cited for: FUNCTION, ENZYME REGULATION, ROLE IN DISEASE, AND PHOSPHORYLATION ATTYR-397. | |
"Cellular characterization of a novel focal adhesion kinaseinhibitor."; Slack-Davis J.K., Martin K.H., Tilghman R.W., Iwanicki M., Ung E.J.,Autry C., Luzzio M.J., Cooper B., Kath J.C., Roberts W.G.,Parsons J.T.; J. Biol. Chem. 282:14845-14852(2007). Cited for: FUNCTION, ENZYME REGULATION, ROLE IN DISEASE, AND PHOSPHORYLATION ATTYR-397. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-397; TYR-570; TYR-576;TYR-577 AND TYR-861, AND MASS SPECTROMETRY. | |
"Therapeutic efficacy of a novel focal adhesion kinase inhibitorTAE226 in ovarian carcinoma."; Halder J., Lin Y.G., Merritt W.M., Spannuth W.A., Nick A.M., Honda T.,Kamat A.A., Han L.Y., Kim T.J., Lu C., Tari A.M., Bornmann W.,Fernandez A., Lopez-Berestein G., Sood A.K.; Cancer Res. 67:10976-10983(2007). Cited for: ENZYME REGULATION, ROLE IN DISEASE, AND PHOSPHORYLATION AT TYR-397 ANDTYR-861. | |
"Time-resolved mass spectrometry of tyrosine phosphorylation sites inthe epidermal growth factor receptor signaling network reveals dynamicmodules."; Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,Lauffenburger D.A., White F.M.; Mol. Cell. Proteomics 4:1240-1250(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-576, AND MASSSPECTROMETRY. | |
"The proto-oncogene Fgr regulates cell migration and this requires itsplasma membrane localization."; Continolo S., Baruzzi A., Majeed M., Caveggion E., Fumagalli L.,Lowell C.A., Berton G.; Exp. Cell Res. 302:253-269(2005). Cited for: FUNCTION IN REGULATION OF CELL MIGRATION, AND PHOSPHORYLATION ATTYR-407; TYR-397 AND TYR-576. | |
"Site-specific phosphorylation of platelet focal adhesion kinase bylow-density lipoprotein."; Relou I.A.M., Bax L.A.B., Van Rijn H.J.M., Akkerman J.-W.N.; Biochem. J. 369:407-416(2003). Cited for: PHOSPHORYLATION AT TYR-397; TYR-407; TYR-577; TYR-861 AND TYR-925, ANDINTERACTION WITH FGR. |